Q3 2021 Holdings
Filed 2021-11-15 | 102 holdings | $1.4B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liquidia Corporation(LQDA)A | COM NEW | 53635D202 | $2.6M | 929,049 | 0.2% |
| Autolus Therapeutics PLC(AUTL)A | SPON ADS | 05280R100 | $2.6M | 398,074 | 0.2% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $2.6M | 160,000 | 0.2% |
| Puma Biotechnology Inc(PBYI)A | COM | 74587V107 | $2.8M | 397,940 | 0.2% |
| Agilent Technologies Inc(A)A | COM | 00846U101 | $2.9M | 18,660 | 0.2% |
| Karuna Therapeutics IncA | COM | 48576A100 | $3.1M | 25,000 | 0.2% |
| Evolent Health Inc(EVH)A | CL A | 30050B101 | $3.1M | 100,170 | 0.2% |
| Intuitive Surgical Inc(ISRG)A | COM NEW | 46120E602 | $3.1M | 3,145 | 0.2% |
| Si-Bone Inc(SIBN)A | COM | 825704109 | $3.2M | 150,000 | 0.2% |
| Dexcom Inc(DXCM)A | COM | 252131107 | $3.5M | 6,401 | 0.2% |
| Merck & Co Inc(MRK)CallA | COM | 58933Y105 | $3.7M | 48,700 | 0.3% |
| Editas Medicine Inc(EDIT)CallA | COM | 28106W103 | $3.7M | 90,000 | 69.6% |
| Surgalign Holdings IncA | COM | 86882C105 | $3.8M | 3,508,536 | 0.3% |
| ARK ETF TR(ARKK)A | INNOVATION ETF | 00214Q104 | $3.9M | 35,000 | 0.3% |
| Apellis Pharmaceuticals Inc(APLS)CallA | COM | 03753U106 | $4.2M | 126,400 | 0.3% |
| Lexicon Pharmaceuticals Inc(LXRX)A | COM NEW | 528872302 | $4.2M | 872,694 | 0.3% |
| Hill-Rom Hldgs Inc(HRC)CallA | COM | 431475102 | $4.4M | 29,400 | 0.3% |
| Hill-Rom Hldgs Inc(HRC)A | COM | 431475102 | $4.5M | 30,000 | 0.3% |
| Gohealth IncA | COM CL A | 38046W105 | $6.3M | 1,261,723 | 0.4% |
| Irhythm Technologies Inc(IRTC)A | COM | 450056106 | $6.7M | 113,854 | 0.5% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $7.4M | 143,109 | 0.5% |
| Healthequity Inc(HQY)A | COM | 42226A107 | $7.4M | 114,378 | 0.5% |
| Horizon Therapeutics PUB LCallA | SHS | G46188101 | $7.7M | 70,000 | 0.5% |
| Nanostring Technologies Inc(NSTGEUR)A | COM | 63009R109 | $8.1M | 168,668 | 0.6% |
| Perkinelmer Inc(RVTY)A | COM | 714046109 | $8.2M | 47,081 | 0.6% |
| Intra-Cellular Therapies Inc(ITCIEUR)A | COM | 46116X101 | $8.6M | 230,744 | 0.6% |
| Centene Corp del(CNC)A | COM | 15135B101 | $8.8M | 141,107 | 0.6% |
| HCA Healthcare Inc(HCA)A | COM | 40412C101 | $9.3M | 38,366 | 0.6% |
| Teva Pharmaceutical Inds LTD(TEVA)CallA | SPONSORED ADS | 881624209 | $9.4M | 962,400 | 0.7% |
| Humana Inc(HUM)A | COM | 444859102 | $9.4M | 24,083 | 0.7% |
| Magellan Health IncA | COM NEW | 559079207 | $9.9M | 104,700 | 0.7% |
| Exelixis Inc(EXEL)A | COM | 30161Q104 | $10.9M | 516,307 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $11.2M | 59,233 | 0.8% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $11.4M | 179,366 | 0.8% |
| Zogenix IncA | COM NEW | 98978L204 | $11.8M | 774,591 | 0.8% |
| Anthem Inc(ELV)A | COM | 036752103 | $11.8M | 31,628 | 0.8% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $12.5M | 259,128 | 0.9% |
| Natera Inc(NTRA)A | COM | 632307104 | $12.5M | 112,189 | 0.9% |
| Guardant Health Inc(GH)A | COM | 40131M109 | $12.5M | 100,361 | 0.9% |
| Community Health SYS Inc New(CYH)CallA | COM | 203668108 | $12.6M | 1,077,200 | 0.9% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $15.1M | 450,501 | 1.0% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $15.4M | 401,654 | 1.1% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $15.5M | 260,895 | 1.1% |
| Astrazeneca PLC(AZN)CallA | SPONSORED ADR | 046353108 | $15.6M | 260,300 | 1.1% |
| Maravai Lifesciences Hldgs I(MRVI)A | COM CL A | 56600D107 | $16.1M | 327,810 | 1.1% |
| R1 RCM IncA | COM | 749397105 | $16.8M | 764,780 | 1.2% |
| Ortho Clinical Diagnostics HA | ORD SHS | G6829J107 | $16.9M | 914,986 | 1.2% |
| Masimo Corp(MASI)A | COM | 574795100 | $18.1M | 67,000 | 1.3% |
| Icon PLC(ICLR)A | SHS | G4705A100 | $18.8M | 71,911 | 1.3% |
| Catalent Inc(CTLTEUR)A | COM | 148806102 | $24.5M | 184,299 | 1.7% |